1. Taiwan, Province of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Neith Corporation

Neith Corporation

6236.TWO
Neith CorporationTW flagTaipei Exchange
17.05
TWD
- -
- -
710.20MMarket Cap
Neith Corporation
6236.TWO
(Taipei Exchange)

Recent

price

17.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.83
4.89
1.44
2.08
7.62
4.55
4
5.41
3.08
1.06
1.38
0.99
0.99
0.96
1.09
- -
0.88
Revenue per Share
-1.17
0.52
-3.2
-0.62
0.38
-1.09
-0.9
-1.71
-1.98
-0.55
-0.34
-0.17
-0.73
-0.96
-0.41
- -
0.08
Basic EPS, GAAP
-0.63
-2.72
-2.55
-2.48
-0.14
-0.32
-0.76
-1.09
-1.32
-0.34
-0.78
0.19
-1.06
-0.42
-0.67
- -
0.23
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.66
6.11
2.45
13.01
8.4
7.31
6.41
4.7
2.72
2.59
2.54
2.37
4.68
4.11
3.7
- -
3.85
Book Value per Share
0.64
6.07
2.4
13
7.66
6.38
5.41
4.14
2.71
2.63
2.32
2.26
6.44
4.19
3.7
- -
3.78
Tangible Book Value per Share
13
6
7
20
32
32
32
32
32
32
32
32
32
42
42
- -
41
Basic Weighted Avg Shares
48
30
10
41
241
144
126
171
97
34
44
31
32
40
46
36
36
Sales/Revenue/Turnover
-33.64
-58.28
-220.41
-11.86
2.89
-32.18
-37.09
-32.53
-54.3
-87.03
-31.01
-29.29
-90.63
-122.43
-54.61
-2.55
-2.55
Operating Margin (%)
1
1
1
1
13
22
18
11
10
12
2
3
5
6
5
5
5
Depreciation Expense
-15
3
-21
-12
12
-35
-28
-54
-63
-17
-11
-5
-24
-40
-17
3
3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-30.6
10.63
-223.01
-30.02
4.92
-23.98
-22.51
-31.69
-64.32
-51.76
-24.77
-17.05
-73.89
-100.33
-37.05
8.74
8.74
Profit Margin (%)
5
34
9
239
136
98
84
21
11
74
49
48
185
150
133
139
139
Working Capital
- -
- -
- -
- -
37
35
33
17
16
3
1
- -
6
1
7
4
4
LT Debt
8
37
16
254
266
225
195
149
90
83
73
72
208
175
154
155
155
Total Equity
- -
-75.87
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.57
-0.57
Return on Invested Capital (%)
- -
13.69
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2.03
2.03
Return on Capital (%)
-94.18
13.95
-79.08
-9.01
4.56
-13.89
-13.11
-30.86
-53.34
-20.67
-13.37
-6.9
-20.95
-24.83
-10.37
2.03
2.03
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
ST Debt
3
3
3
LT Borrowings
- -
- -
- -
LT Finance Leases
6
5
4
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
42
42
42
Market Capitalization
1,174
1,272
881

Working Capital

FRC

•

in mil. unless spec.
Jun'25
Sep'25
Dec'25
Total Current Assets
147
146
148
Cash, Cash Equivalents & STI
137
139
141
Accounts Receivable, Net
6
5
5
Inventories
- -
- -
- -
Total Current Liabilities
9
9
9
Payables & Accruals
- -
- -
- -
ST Debt
3
3
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.51%
32.21%
0.34%
Free Cash Flow
-66.46%
-183.99%
-133.19%
Net Income, GAAP
16.3%
36.9%
-118.7%
Sales/Revenue/Turnover
-6.32%
-1.62%
-20.68%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
9
16
7
8
40
2024
9
15
10
11
46
2025
12
8
8
8
36

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
-0.31
-0.14
-0.23
- -
-0.96
2024
-0.27
-0.08
-0.09
- -
-0.41
2025
0.07
- -
-0.02
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
ObsEva S.A. (OBSN.SW)
OncoTherapy Science, Inc. (4564.T)
Quia Pharma AB (publ) (QUIA.ST)
Genomic Valley Biotech Ltd (GVBL.BO)
CStone Pharmaceuticals (CSPHF)
Geffen Residence & Renewal Ltd (GEFR.TA)
Business
Neith Corporation (6236.TWO) engages in the biotechnology, medical cosmetics, preventive medicine, and semiconductor businesses, primarily manufacturing and selling nutritional supplements, health and beauty equipment, skincare products, genetic testing services, and integrated circuit components. The company offers core nutritional products including L-One, a liquid formula for eye health maintenance; EPlus, a multiple enzyme supplement; and other supplements under the King One brand; genetic testing services; energy and dual-purpose products such as mattresses, masks, silicon gel necklaces, waistbands, heating stones, massage rods, water purifiers, and Ganbanyoku energy stone spa beds incorporating FIR-tech materials; beauty care items like cell regeneration and rejuvenation skincare series; home energy products; and microcontrollers with peripherals. Founded in 1997 and headquartered in Taichung, Taiwan, Neith Corporation operates principally in the Taiwan market with a focus on healthcare, wellness, and technology sectors targeting individual consumers and health-conscious customers. The company, formerly known as Come True Biomedical Inc., maintains its primary operations without major recent acquisitions, partnerships, funding rounds, or strategic shifts reported in the last two years.